Document:

EXCHANGE AGREEMENT

                                  by and among

                                 EUROTECH, LTD.

                                CRYPTO.COM, INC.

                           MARKLAND TECHNOLOGIES, INC.

                            SECURITY TECHNOLOGY, INC.

           and, solely with respect to ARTICLE V AND ARTICLE XI hereof

                                IPPARTNERS, INC.

          and, solely with respect to ARTICLE VI and ARTICLE XI hereof

                                  MARKLAND LLC

                                       AND

                                    JAMES LLC

                                December 9, 2002

<PAGE>

                                Table of Contents

ARTICLE I. Closing; The Exchange; The Exchange Procedures_____________________1

ARTICLE II. Exchange of Certificates__________________________________________2

ARTICLE III. Representations and Warranties of the Company and Crypto_________2

ARTICLE IV. Representations and Warranties of Markland and STI________________7

ARTICLE V. Representations and Warranties of the Company and ipPartners_______10

ARTICLE VI. Representations and Warranties of the Markland Shareholders_______11

ARTICLE VII. Covenants________________________________________________________12

ARTICLE VIII. Conditions______________________________________________________15

ARTICLE IX. Termination_______________________________________________________17

ARTICLE X. Indemnification and Survival_______________________________________18

ARTICLE XI. Patriot Act and Other Representations of the Parties______________20

ARTICLE XII. Miscellaneous and General________________________________________21

Transferred Property__________________________________________________________ i

<PAGE>

                               Exchange Agreement

                               EXCHANGE AGREEMENT

         This EXCHANGE AGREEMENT (this "Agreement"), dated as of December 9,
2002 (the "Agreement Date"), is by and among Eurotech, Ltd., a District of
Columbia corporation (the "Company"), Crypto.com, Inc., a Delaware corporation
("Crypto"), Markland Technologies, Inc., a Florida corporation ("Markland"),
Security Technology, Inc., a Delaware corporation, a wholly owned subsidiary of
Markland ("STI"), and, solely with respect to ARTICLE V and ARTICLE XI hereof,
ipPartners, Inc., a Rhode Island corporation ("ipPartners"), and, solely with
respect to ARTICLE VI and ARTICLE XI hereof, Markland LLC, a Cayman Island
limited liability company, and, solely with respect to ARTICLE VI and ARTICLE XI
hereof, James LLC, a Cayman Island limited liability company (Markland LLC and
James LLC, together being the "Markland Shareholders").

                                    RECITALS

         WHEREAS, the Company desires to acquire from Markland and Markland
agrees to issue two hundred thirty-nine million nine hundred twenty-seven
thousand three hundred forty four (239,927,344) shares of common stock of
Markland, $0.0001 par value per share (the "Markland Common Stock"),
representing eighty percent (80%) of the issued and outstanding shares of
Markland Common Stock (such shares, the "Exchange Shares"), upon the terms and
subject to the conditions set forth in this Agreement;

         WHEREAS, the Company desires to exchange, and shall cause its majority
owned Subsidiary Crypto to exchange, all right, title and interest held by each
of the Company and Crypto, respectively, in the intellectual property and other
associated assets, as further described in Exhibit A attached hereto (the
"Transferred Property"), to STI as consideration for the Exchange Shares, upon
the terms and subject to the conditions set forth in this Agreement;

         WHEREAS, Markland agrees to issue twenty-nine million nine hundred
ninety thousand nine hundred seventeen (29,990,917) shares of Markland Common
Stock, that when issued will represent ten percent (10%) of the issued and
outstanding shares of Markland Common Stock ("ipPartners Shares"), upon the
terms and subject to the conditions set forth in this Agreement;

         WHEREAS, the respective Boards of Directors of all of the parties
hereto have approved this Agreement and the Exchange upon the terms and subject
to the conditions set forth in this Agreement;

         WHEREAS, as soon as practicable following the consummation of the
Exchange (as defined below), the Company, as majority shareholder of Markland,
shall approve and effect a 1-for-20 reverse split of the Markland Common Stock;
and

         WHEREAS, the parties hereto desire to make certain representations,
warranties, covenants and agreements in connection with this Agreement.

         NOW, THEREFORE, in consideration of the premises, and of the
representations, warranties, covenants and agreements contained in this
Agreement, and for other good and valuable consideration, the receipt and
sufficiency of which is acknowledged by the parties hereto, the parties agree as
follows:

                                       1
<PAGE>

                                   ARTICLE I.

                 Closing; The Exchange; The Exchange Procedures

1.1 Closing. The closing of the Exchange and the other transactions contemplated
hereby (the "Closing") shall be made at such time and place as the parties may
mutually agree, on or before December 15, 2002 (the "Closing Date").

1.2 The Exchange and the Exchange Procedures. At the Closing, Markland shall
issue to the Company and to ipPartners, respectively, 239,927,344 shares and
29,990,917 shares of Markland Common Stock representing, respectively, the
Exchange Shares and the ipPartners Shares, and simultaneously therewith, and
conditioned thereupon, the Company shall transfer and deliver, and shall cause
Crypto to transfer and deliver, the Transferred Property to STI in exchange for
the Exchange Shares. In consideration of its receipt of the ipPartners Shares,
ipPartners shall forgive and discharge certain obligations owed to ipPartners
with respect to the Transferred Property. At the Closing, the Transferred
Property shall be transferred to STI pursuant to an assignment and assumption
agreement to be entered into between the Company, Crypto, Markland and STI,
which assignment and assumption agreement shall be in the form attached hereto
as Exhibit B. The exchange of the Exchange Shares and the Transferred Property
as contemplated herein as referred to herein as the "Exchange."

                                  ARTICLE II.

                            Exchange of Certificates

2.1 Lost, Stolen or Destroyed Certificates. In the event any share certificate
representing the Exchange Shares of the ipPartners Shares (each a "Certificate)
shall have been lost, stolen or destroyed, upon the making of an affidavit of
that fact by the party claiming such Certificate to be lost, stolen or destroyed
and the posting by such party of a bond in the form customarily required by
Markland as indemnity against any claim that may be made against it with respect
to such Certificate, Markland will issue a replacement certificate in respect
thereof in exchange for such lost, stolen or destroyed Certificate pursuant to
Section 1.2.

                                  ARTICLE III.

            Representations and Warranties of the Company and Crypto

The Company and Crypto hereby represent and warrant to Markland that:

3.1 Organization, Good Standing. Each of the Company and Crypto is a corporation
duly organized, validly existing and in good standing under the laws of the
District of Columbia and the State of Delaware, respectively, and has all
requisite corporate or similar power and authority to own and operate its
properties and assets and to carry on its business as presently conducted and is
qualified to do business and is in good standing as a foreign corporation in
each jurisdiction where the ownership or operation of its properties or conduct
of its business requires such qualification, except where the failure to be so
qualified or in good standing is not, when taken together with all other such
failures, reasonably likely to have a Material Adverse Effect (as defined below)
on it.

                                       2
<PAGE>

         As used in this Agreement, the term "Material Adverse Effect" means,
with respect to any Person, a material adverse effect on the financial
condition, assets or liabilities or business of such Person and its Subsidiaries
(as defined below), taken as a whole; provided, however, that Material Adverse
Effect shall exclude any effect resulting from or related to changes or
developments involving (1) a prospective change arising out of any proposed or
adopted legislation, or any other proposal or enactment by any governmental,
regulatory or administrative authority, (2) general conditions applicable to the
economy of the United States, including changes in interest rates, (3)
conditions or effects resulting from the announcement of the existence or terms
of this Agreement or (4) conditions affecting the technology industry, in each
case taken as a whole.

3.2 Corporate Authority and Approval. Each of the Company and Crypto has all
requisite corporate power and authority and has taken all corporate action
necessary in order to execute, deliver and perform its obligations under this
Agreement. This Agreement has been duly executed and delivered by each of the
Company and Crypto and is a valid and binding agreement of each of them and
enforceable against each of them in accordance with its terms, subject to
bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and
similar laws of general applicability relating to or affecting creditors' rights
and to general equity principles (the "Bankruptcy and Equity Exception"). The
Board of Directors of each of the Company and Crypto has unanimously approved
this Agreement and the other transactions contemplated by this Agreement.

3.3      Government Filings; No Violations.

    (a) Except for filings required pursuant to the Securities Exchange Act of
1934,  as  amended,  or  the  rules  and  regulations   promulgated   thereunder
(collectively, the "Exchange Act") or any other federal or state securities laws
or any stock exchange or other self regulatory organization, no notices, reports
or other  filings are  required to be made by either the Company or Crypto with,
nor  are any  consents,  registrations,  approvals,  permits  or  authorizations
required to be obtained by either the Company or Crypto from,  any  governmental
or regulatory authority,  court, agency, commission,  body or other governmental
entity ("Governmental Entity"), in connection with the execution and delivery of
this  Agreement  by  the  Company  and  Crypto  and  the   consummation  of  the
transactions  contemplated by this  Agreement,  except those that the failure to
make or obtain are not,  individually or in the aggregate,  reasonably likely to
have a Material Adverse Effect on any of the Company,  Crypto or the Transferred
Property, nor prevent,  materially delay or materially impair the ability of the
Company or Crypto to consummate the transactions contemplated by this Agreement.

                                       3
<PAGE>

    (b) The execution, delivery and performance of this Agreement by each of the
Company or Crypto does not, and the consummation of the other transactions
contemplated by this Agreement will not, constitute or result in (A) a breach or
violation of, or a default under, the certificate of incorporation or bylaws of
each of the Company or Crypto, (B) a breach or violation of, or a default under,
the acceleration of any obligations or the creation of a lien, pledge, security
interest or other encumbrance on the assets of each of the Company or Crypto
(with or without notice, lapse of time or both) pursuant to, any agreement,
lease, contract, note, mortgage, indenture, arrangement or other obligation
("Contracts") binding upon them or any law, statute, ordinance, regulation,
judgment, order, decree, injunction, arbitration award, license, authorization,
opinion, agency requirement or permit of any Governmental Entity or common law
(each, a "Law" and collectively, "Laws") to which they are subject or (C) any
change in the rights or obligations of any party under any Contracts to which
either the Company or Crypto is a party, except, in the case of clauses (B) or
(C) above, for any breach, violation, default, acceleration, creation or change
that, individually or in the aggregate, is not reasonably likely to have a
Material Adverse Effect on the Company and Crypto, or the Transferred Property
or prevent, materially delay or materially impair the ability of the Company and
Crypto to consummate the transactions contemplated by this Agreement. Schedule
3.3(b) ("Prior Contracts") sets forth a correct and complete list of Contracts
of the Company and Crypto pursuant to which consents or waivers are or may be
required prior to consummation of the transactions contemplated by this
Agreement other than those where the failure to obtain such consents or waivers
is not, individually or in the aggregate, reasonably likely to have a Material
Adverse Effect on the Company or Crypto or prevent or materially impair their
ability to consummate the transactions contemplated by this Agreement.

3.4 Reports; Financial Statements. The Company is a reporting company under
the Exchange  Act and the shares of the  Company's  common stock are  registered
under  Section  12(g) of the  Exchange  Act.  The Company has made  available to
Markland,  through  electronic  filings on EDGAR, each  registration  statement,
report,  proxy statement or information  statement prepared by it since December
31, 2000, including its Annual Report on Form 10-KSB for the year ended December
31, 2001 and its Quarterly  Reports on Form 10-QSB for the quarters  ended since
December 31, 2000, in the form (including  exhibits,  annexes and any amendments
thereto)  filed  with  the  Securities  and  Exchange   Commission  (the  "SEC")
(collectively,  including  any  such  registration  statements,  reports,  proxy
statements or information statements filed subsequent to the Agreement Date, its
"Reports"). Since June 30, 2000, the Company has made all filings required to be
made by the  Securities  Act of 1933,  or any  successor  law, and the rules and
regulations  issued pursuant  thereto (the  "Securities  Act"), and the Exchange
Act. As of their  respective  dates,  the Company's  Reports complied as to form
with all applicable  requirements  and did not contain any untrue statement of a
material fact or omit to state a material fact required to be stated  therein or
necessary to make the statements made therein,  in light of the circumstances in
which  they  were  made,  not  misleading.  The  financial  statements  and  any
supporting   schedules  of  the  Company  and  its   Subsidiaries   included  or
incorporated   by  reference  in  the  Company's   Reports  present  fairly  the
consolidated  financial  position of the Company and its  Subsidiaries as of the
dates indicated and the consolidated results of their operations for the periods
specified  (subject,  in the case of unaudited  statements,  to notes and normal
year-end audit  adjustments  that will not be material in amount or effect),  in
each case in accordance  with generally  accepted  accounting  principles of the
United States consistently applied ("GAAP") during the periods involved,  except
as may be noted therein.

                                       4
<PAGE>

3.5 Litigation and Liabilities. Except as disclosed in the Company's Reports
filed prior to the Closing Date or on Schedule 3.5, there are no (i) civil,
criminal or administrative actions, suits, claims, hearings, investigations or
proceedings pending or, to the actual knowledge of its executive officers,
threatened against the Company or any of its Affiliates with respect to the
Transferred Property or (ii) obligations or liabilities, whether or not accrued,
contingent or otherwise and whether or not required to be disclosed with respect
to the Transferred Property, or any other facts or circumstances, in either such
case, of which its executive officers have actual knowledge and that are
reasonably likely to result in any claims against or obligations or liabilities
of the Company or any of its Affiliates, except for those that are not,
individually or in the aggregate, reasonably likely to have a Material Adverse
Effect on the Company or Crypto, or prevent, materially delay or materially
impair its ability to consummate the transactions contemplated by this
Agreement.

    For purposes of this Agreement, the term "Affiliate" means, with
respect to any person or entity, any person or entity that, directly or
indirectly, controls, is controlled by, or is under common control with, such
Person. For purposes of this definition, "control" shall mean the possession,
directly or indirectly, of the power to direct or cause the direction of the
management and policies of such Person, whether through the ownership of voting
securities or by contract or otherwise.

3.6 Compliance with Laws. Except as disclosed in the Company's Reports filed
prior to the Closing Date or on Schedule 3.6, the businesses of the Company and
Crypto with respect to the Transferred Property have not been, and are not
being, conducted in violation of Law, except for violations or possible
violations that are not, individually or in the aggregate, reasonably likely to
have a Material Adverse Effect on the Transferred Property or prevent,
materially delay or materially impair its ability to consummate the transactions
contemplated by this Agreement. Except as disclosed on Schedule 3.6, no
investigation or review by any Governmental Entity with respect to the Company
or Crypto is pending or, to the actual knowledge of its executive officers,
threatened, nor has any Governmental Entity indicated an intention to conduct
the same, except for those the outcome of which are not, individually or in the
aggregate, reasonably likely to have a Material Adverse Effect on it or prevent,
materially delay or materially impair their ability to consummate the
transactions contemplated by this Agreement. To the actual knowledge of its
executive officers, no material change is required in the Company's or Crypto's
processes, properties or procedures in connection with any such Laws, and it has
not received any notice or communication of any material noncompliance with any
such Laws that has not been cured as of the Closing Date, except for such
changes and noncompliance that are not, individually or in the aggregate,
reasonably likely to have a Material Adverse Effect on them or prevent,
materially delay or materially impair their ability to consummate the
transactions contemplated by this Agreement.

3.7 Brokers and Finders. Neither the Company nor any of its officers,
directors  or  employees  has  employed  any  broker or finder or  incurred  any
liability for any  brokerage  fees,  commissions  or finders' fees in connection
with the Exchange or the other transactions contemplated in this Agreement.

                                       5
<PAGE>

3.8 Tangible Personal Property. Schedule 3.8 is a complete and accurate
schedule  describing,  and specifying  the location of, all material  machinery,
equipment,  furniture, supplies, tools, drawings and all other tangible personal
property and all motor  vehicles  owned by, in the possession of, or used by the
Company  and  Crypto in  connection  with  their  business  with  respect to the
Transferred  Property.  The property listed in Schedule 3.8 constitutes all such
material  tangible  personal  property  used or necessary for the conduct by the
Company  and  Crypto  of its  business  as now  conducted  with  respect  to the
Transferred Property. Except as stated in Schedule 3.8 or otherwise disclosed in
this  Agreement,  no personal  property  used by either the Company or Crypto in
connection with each of its businesses with respect to the Transferred  Property
is held under or subject to any lease,  security  agreement,  conditional  sales
contract or other title  retention or security  arrangement  or is located other
than in the possession of either the Company or Crypto.

3.9 Trademarks, Tradenames, etc. Schedule 3.9 to this Agreement is a
schedule of all trade names, trademarks, service marks, and copyrights and their
registrations,  owned by either the Company or Crypto,  or in which each of them
has any rights or licenses,  together  with a brief  description  of each,  with
respect to the Transferred  Property. To the knowledge of the Company and except
as disclosed on Schedule 3.9,  neither the Company nor Crypto has infringed,  or
is now  infringing  on any trade  name,  trademark,  service  mark or  copyright
belonging  to any  other  person,  firm,  or  corporation  with  respect  to the
Transferred  Property.  Each of the Company and Crypto owns,  or holds  adequate
licenses or other rights to use, all trademarks,  service marks, trade names and
copyrights  necessary  for the  business as now  conducted  by each of them with
respect  to  the  Transferred  Property  and  are  not  subject  to  any  liens,
encumbrances,  taxes,  maintenance  fees,  royalty  fees,  license fees or other
obligations  for payment  that may become due  subsequent  to the  Closing  Date
(including  without  limitation  those listed in Schedule 3.9), and their use in
such business does not, and will not,  conflict with,  infringe on, or otherwise
violate any rights of others.

3.10 Patents, etc. Schedule 3.10 to this Agreement is a complete schedule of
all patents, inventions,  industrial models, processes, designs and applications
for patents  owned by the  Company or Crypto,  or in which they have any rights,
licenses,  or  immunities  with  respect  to the  Transferred  Property.  To the
Company's knowledge, the patents and applications for patents listed in Schedule
3.10 are valid and in full force and  effect  and are not  subject to any liens,
encumbrances,  taxes,  maintenance  fees,  royalty  fees,  license fees or other
obligations  for payment  that may become due  subsequent  to the Closing  Date.
Except as set  forth in  Schedule  3.10,  there  have not been any  interference
actions  or  other  judicial,   arbitration,   or  other  adversary  proceedings
concerning the patents or applications for patents listed in Schedule 3.10. Each
patent  application is awaiting action by its respective patent office except as
otherwise  indicated  in  Schedule  3.10.  To  the  Company's   knowledge,   the
manufacture,  use,  or sale of the  inventions,  models,  designs,  and  systems
covered by the patents and  applications  for patents listed in Schedule 3.10 do
not violate or infringe on any patent or any  proprietary  or personal  right of
any person, firm, or corporation.  To the Company's  knowledge,  the neither the
Company nor Crypto has  infringed,  nor is now infringing on any patent or other
right belonging to any person, firm, or corporation. To the Company's knowledge,
each  of the  Company  and  Crypto  has  the  right  and  authority  to use  the
inventions,  trade secrets,  processes,  models, designs, and formulas listed on
Schedule 3.10 and their use in such  business  does not, and will not,  conflict
with, infringe on, or violate any patent or other rights of others.

                                       6
<PAGE>

3.11 Trade Secrets. To the Company's knowledge, each of the Company and
Crytpo  is the sole  owner of each of its  trade  secrets  with  respect  to the
Transferred Property, free and clear of any liens,  encumbrances,  restrictions,
or legal or equitable claims of others,  taxes,  maintenance fees, royalty fees,
license fees or other  obligations for payment that may become due subsequent to
the Closing Date except as  specifically  stated in Schedule  3.11.  Each of the
Company  and Crytpo  has taken  reasonable  security  measures  to  protect  the
secrecy,  confidentiality  and value of its trade secrets;  any of its employees
and any other  persons who,  either alone or in concert with others,  developed,
invented, discovered, derived, programmed or designed these secrets, or who have
knowledge of or access to information  relating to them, have been put on notice
and if  appropriate,  have  entered  into  agreements  that  these  secrets  are
proprietary  to the Company or Crypto,  respectively,  and not to be divulged or
misused.

                                  ARTICLE IV.

               Representations and Warranties of Markland and STI

Markland and STI hereby represent and warrant to the Company and ipPartners
that:

4.1 Organization, Good Standing and Qualification. Markland and its wholly
owned subsidiary STI each is a corporation duly organized,  validly existing and
in good standing under the laws of its respective  jurisdiction  of organization
and has all requisite  corporate or similar power and authority and is qualified
to do  business  and is in  good  standing  as a  foreign  corporation  in  each
jurisdiction  where the  ownership or operation of its  properties or conduct of
its  business  requires  such  qualification,  except where the failure to be so
qualified or in good  standing is not,  when taken  together with all other such
failures,  reasonably  likely to have a Material  Adverse Effect on it. Markland
has made available to the Company a complete and correct copy of its certificate
of  incorporation  and bylaws,  each as amended to date.  Such  certificates  of
incorporation and bylaws are in full force and effect.

4.2 Capital Structure. The authorized capital stock of Markland consists of
500,000,000 shares of Markland Common Stock, of which 299,909,179 shares shall
be issued and outstanding as of the Closing Date, inclusive of the Exchange
Shares and the ipPartners Shares. All of the outstanding shares of Markland
Common Stock, including the Exchange Shares and the ipPartners Shares when
issued at the Closing pursuant to this Agreement, have been or will be duly
authorized, validly issued, fully paid and nonassessable. Except as disclosed in
this Section 4.2 or on Schedule 4.2, as of the Closing Date, there are no
additional issued and outstanding shares of Markland Common Stock. All of the
outstanding shares of capital stock of STI are duly authorized, validly issued,
fully paid and nonassessable, and owned by Markland, free and clear of any lien,
pledge, security interest, claim or other encumbrance.

4.3 Corporate Authority and Approval. Markland and its wholly owned
subsidiary  STI each has all  requisite  corporate  power and  authority and has
taken all corporate  action  necessary in order to execute,  deliver and perform
its obligations under this Agreement.  This Agreement has been duly executed and
delivered  by  Markland  and is a  valid  and  binding  agreement  of  Markland,
enforceable  against  Markland  in  accordance  with its  terms,  subject to the
Bankruptcy  and  Equity  Exception.  The  Board of  Directors  of  Markland  has
unanimously approved this Agreement.

                                       7
<PAGE>

4.4 Government Filings; No Violations.

       (a) Except for filings required pursuant to the Exchange Act, no notices,
reports or other filings are required to be made by Markland with, nor are any
consents, registrations, approvals, permits or authorizations required to be
obtained by Markland from, any Governmental Entity, in connection with the
execution and delivery of this Agreement by it and the other transactions
contemplated by this Agreement, except those that the failure to make or obtain
are not, individually or in the aggregate, reasonably likely to have a Material
Adverse Effect on Markland or prevent, materially delay or materially impair its
ability to consummate the transactions contemplated by this Agreement.

       (b) The execution, delivery and performance of this Agreement by Markland
does not, and the consummation by it of the Exchange and the other  transactions
contemplated by this Agreement will not, constitute or result in (A) a breach or
violation of, or a default under,  its certificate of incorporation or bylaws or
the comparable governing instruments of any of its Subsidiaries, (B) a breach or
violation of, or a default under,  the  acceleration  of any  obligations or the
creation of a lien, pledge, security interest or other encumbrance on its assets
or the assets of any of its Subsidiaries (with or without notice,  lapse of time
or both) pursuant to, any Contract binding upon it or any of its Subsidiaries or
any Law to which it or any of its  Subsidiaries  is subject or (C) any change in
the rights or  obligations  of any party under any  Contracts to which it or its
Subsidiaries are a party,  except,  in the case of clauses (B) or (C) above, for
any  breach,  violation,  default,   acceleration,   creation  or  change  that,
individually  or in the aggregate,  is not reasonably  likely to have a Material
Adverse  Effect on it or  prevent,  materially  delay or  materially  impair its
ability to consummate the transactions contemplated by this Agreement.

4.5 Reports; Financial Statements. Markland is a reporting company under the
Exchange Act and the shares of Markland Common Stock are registered under
Section 12(g) of the Exchange Act. Markland has made available to the Company,
through electronic filings on EDGAR, each registration statement, report, proxy
statement or information statement prepared by it since June 30, 2000, including
its Annual Report on Form 10-KSB for the years ended June 30, 2001 and June 30,
2002 and its Quarterly Reports on Form 10-QSB for the quarters ended since June
30, 2000, in the form (including exhibits, annexes and any amendments thereto)
filed with the SEC (collectively, including any such registration statements,
reports, proxy statements or information statements filed subsequent to the
Agreement Date, its "Reports"). Since June 30, 2000, Markland has made all
filings required to be made by the Securities Act and the Exchange Act. As of
their respective dates, the Markland Reports complied as to form with all
applicable requirements and did not contain any untrue statement of a material
fact or omit to state a material fact required to be stated therein or necessary
to make the statements made therein, in light of the circumstances in which they
were made, not misleading. The financial statements and any supporting schedules
of Markland and its Subsidiaries included or incorporated by reference in the
Markland Reports present fairly the consolidated financial position of Markland
and its Subsidiaries as of the dates indicated and the consolidated results of
their operations for the periods specified (subject, in the case of unaudited
statements, to notes and normal year-end audit adjustments that will not be
material in amount or effect), in each case in accordance with GAAP consistently
applied during the periods involved, except as may be noted therein. To the
knowledge of the directors, officers, employees and legal and accounting
representatives of Markland, except as disclosed on Schedule 4.5, as of the
Closing Date, no Person or group beneficially owns 10% or more of the
outstanding voting securities of the Company. As used in this Section 4.5, the
terms "beneficially owns" and "group" shall have the meanings ascribed to such
terms under Rule 13d-3 and Rule 13d-5 under the Exchange Act.

                                        8
<PAGE>

4.6 Litigation and Liabilities. Except as disclosed in Markland's Reports
filed  prior  to  the  Closing  Date,  there  are  no  (i)  civil,  criminal  or
administrative actions, suits, claims,  hearings,  investigations or proceedings
pending  or, to the  actual  knowledge  of its  executive  officers,  threatened
against  Markland or any of its Affiliates or (ii)  obligations or  liabilities,
whether or not accrued,  contingent  or otherwise and whether or not required to
be disclosed,  including those relating to matters  involving any  Environmental
Law, or any other  facts or  circumstances,  in either  such case,  of which its
executive  officers  have actual  knowledge  and that are  reasonably  likely to
result in any claims against or obligations or liabilities of Markland or any of
its Affiliates, except for those that are not, individually or in the aggregate,
reasonably  likely to have a Material  Adverse  Effect on  Markland  or prevent,
materially delay or materially impair its ability to consummate the transactions
contemplated by this Agreement.

4.7 Compliance with Laws.Markland currently conducts no business operations.
Except as disclosed in Markland's Reports filed prior to the Closing Date, the
businesses of Markland and its Subsidiaries have not been conducted in violation
of any Laws. Except as disclosed in the Markland's Reports filed prior to the
Closing Date, no investigation or review by any Governmental Entity with respect
to the Markland or any of its Subsidiaries is pending or, to the actual
knowledge of its executive officers, threatened, nor has any Governmental Entity
indicated an intention to conduct the same, except for those the outcome of
which are not, individually or in the aggregate, reasonably likely to have a
Material Adverse Effect on it or prevent, materially delay or materially impair
its ability to consummate the transactions contemplated by this Agreement.

4.8 Insurance. Schedule 4.8 to this Agreement is a complete list accurately
describing all insurance policies held by Markland concerning its businesses and
properties and any officer or director of Markland. All such policies are in the
respective principal amounts set forth in Schedule 4.8 and are in full force and
effect as of the Closing Date. Markland has not received written notice of any
pending or threatened termination or retroactive premium increase with respect
such policies, and Markland is in compliance in all material respects with all
conditions contained therein. There are no pending claims against such insurance
by Markland or any individual or entity covered under such policies as to which
insurers have denied liability and no defenses provided by insurers under
reservations of rights. Markland does not self insure any risk under any such
policies other than applicable deductibles. None of the policies listed on
Schedule 4.8 shall terminate or be terminable pursuant to their terms as a
result of the consummation of the transactions contemplated hereby.

                                       9
<PAGE>

4.9 Brokers and Finders. Neither Markland nor any of its officers, directors
or employees has employed any broker or finder or incurred any liability for any
brokerage fees,  commissions or finders' fees in connection with the Exchange or
the other transactions contemplated in this Agreement.

                                   ARTICLE V.

          Representations and Warranties of the Company and ipPartners

         Each of the Company and ipPartners (for these purposes, each, a
"Stockholder") severally (and not jointly) represents and warrants to Markland,
solely with respect to each as a Stockholder, that:

5.1 Accredited Investor. The Stockholder is an "accredited investor" (as such
term is defined in Rule 501 of Regulation D promulgated under the Securities
Act), and has such knowledge and experience in financial business matters that
the Stockholder is capable of evaluating the merits and risks of the Exchange.
The Stockholder's residence or, if other than a natural person, its principal
office, is located in the jurisdiction indicated in the address of such
Stockholder opposite its name on the signature page hereof.

5.2 Review of SEC Filings. The Stockholder has had the opportunity to review the
Markland's Reports.

5.3 Opportunity for Investigation. Markland has given the Stockholder the
opportunity to meet with Markland's directors and executive officers for the
purpose of asking questions and receiving answers concerning the terms and
conditions of the Exchange, and to obtain any additional information that
Markland may possess or can acquire without unreasonable effort or expense that
is necessary to verify the accuracy of any information that Markland has
furnished the Stockholder in connection with the Exchange.

5.4 Restricted Securities. The Stockholder understands and acknowledges that the
Exchange Shares and the ipPartners Shares being issued to the respective
Stockholders in the Exchange are "restricted securities," (as such terms is
defined in Securities and Exchange Commission ("SEC") Rule 144(a)(3)) that the
certificate or certificates evidencing those shares will bear a legend,
substantially in the form set forth below, indicating that those shares are
restricted securities, and that those shares may not be transferred except
pursuant to an effective registration statement under the Securities Act or an
available exemption from such registration.

         The legend referred to above will be substantially as follows:

         "These securities have been issued pursuant to an exemption under the
         Securities Act of 1933 and are restricted securities, and neither such
         securities nor any interest therein may be offered, sold, pledged,
         hypothecated, made the subject of a gift or otherwise transferred, for
         value or otherwise, without the written approval of counsel for the
         issuer making specific reference to this certificate. The transfer
         agents of the issuer have been instructed to register transfers of the
         shares evidenced by this certificate only in accordance with the
         foregoing instructions."

                                       10
<PAGE>

5.5 Stockholder's  Intent.  The Stockholder is acquiring the Exchange Shares and
the  ipPartners   Shares,   respectively,   and  such  acquisition  is  for  the
Stockholder's own account, for investment purposes,  and not with a view towards
their distribution.

5.6  Enforceability.  This  Agreement  is the  Stockholder's  valid and  binding
obligation, enforceable against the Stockholder in accordance with it terms.

                                   ARTICLE VI.

           Representations and Warranties of the Markland Shareholders

         Each of the Markland Shareholders severally (and not jointly) hereby
represents and warrants to the Company and ipPartners, solely with respect to
each as a shareholder of Markland that:

6.1 Corporate Authority and Approval. Each of the Markland Shareholders has all
requisite corporate power and authority in order to surrender 269,918,261 shares
of Markland Common Stock, in aggregate, to Markland for retirement by Markland
to treasury stock on or prior to the Exchange (the "Share Surrender"). This
Agreement has been duly executed and delivered by each of the Markland
Shareholders and is a valid and binding agreement of, enforceable against each
of the Markland Shareholders in accordance with its terms, subject to the
Bankruptcy and Equity Exception.

6.2 Government Filings; No Violations.

       (a) Except for filings required pursuant to the Exchange Act or any other
federal or state securities laws or any stock exchange or other self regulatory
organization, no notices, reports or other filings are required to be made by
either the Markland Shareholders with, nor are any consents, registrations,
approvals, permits or authorizations required to be obtained by the Markland
Shareholders from, any Governmental Entity, in connection with the Share
Surrender, except those that the failure to make or obtain are not, individually
or in the aggregate, reasonably likely to have a Material Adverse Effect on the
Exchange Shares or the ipPartners Shares.

       (b) The Share Surrender by the Markland Shareholders does not, and the
consummation of the other transactions contemplated by this Agreement will not,
constitute or result in (A) a breach or violation of, or a default under, the
governing documents of either Markland Shareholder, (B) a breach or violation
of, or a default under, the acceleration of any obligations or the creation of a
lien, pledge, security interest or other encumbrance on the shares to be retired
in connection with the Share Surrender, (with or without notice, lapse of time
or both) pursuant to any Contract binding upon them or any Law to which they are
subject or (C) any change in the rights or obligations of any party under any
Contracts to which either Markland Shareholder is a party, except, in the case
of clauses (B) or (C) above, for any breach, violation, default, acceleration,
creation or change that, individually or in the aggregate, is not reasonably
likely to have a Material Adverse Effect on, or prevent, materially delay or
materially impair the ability of the Markland Shareholders to consummate the
Share Surrender.

                                       11
<PAGE>

6.3 Litigation and Liabilities. There are no (i) civil, criminal or
administrative actions, suits, claims, hearings, investigations or proceedings
pending or, to the actual knowledge of its executive officers, threatened
against the Markland Shareholders or any of their respective Affiliates with
respect to the shares to be retired in connection with the Share Surrender or
(ii) obligations or liabilities, whether or not accrued, contingent or otherwise
and whether or not required to be disclosed with respect to the shares to be
retired in connection with the Share Surrender, or any other facts or
circumstances, in either such case, of which the executive officers of the
Markland Shareholders have actual knowledge and that are reasonably likely to
result in any claims against or obligations or liabilities of the Markland
Shareholders or any of their respective Affiliates, except for those that are
not, individually or in the aggregate, reasonably likely to have a Material
Adverse Effect on the shares to be retired in connection with the Share
Surrender, or prevent, materially delay or materially impair the ability of the
Markland Shareholders to consummate the Share Surrender.

6.4 Brokers and Finders. Neither of the Markland Shareholders, nor any of its
respective officers, directors or employees, has employed any broker or finder
or incurred any liability for any brokerage fees, commissions or finders' fees
in connection with the Exchange or the other transactions contemplated in this
Agreement.

                                  ARTICLE VII.

                                    Covenants

                             Post-Closing Covenants

7.1      Financial Statements.

       (a) The parties shall cooperate in preparing and/or causing to be
prepared the information and financial statements required by Form 8-K under the
Exchange Act. As soon as  practicable  after the Closing  Date,  but in no event
later than forty-five  (45) days after the Closing Date,  Markland shall deliver
its audited financial statements as of and for the year ended June 30, 2002, and
such audit shall have been conducted by such accounting firm mutually acceptable
to the parties.

7.2      Access; Consultation.

       (a) Upon reasonable notice, and except as may be prohibited by applicable
Law,  Markland  and Company each shall (and shall cause their  Subsidiaries  to)
afford to the other and the employees, agents and representatives (including any
attorney or accountant  retained by either  party) of either party,  as the case
may be,  reasonable  access,  during normal business hours throughout the period
prior to the Closing Date, to its properties,  books, Contracts and records and,
during such period,  each shall (and shall cause their  Subsidiaries to) furnish
promptly to the other all  information  concerning its business,  properties and
personnel  as may  reasonably  be  requested,  provided  that  no  investigation
pursuant  to  this  Section  7.2  shall  affect  or  be  deemed  to  modify  any
representation or warranty under this Agreement, and provided, further, that the
foregoing shall not require Markland or the Company to permit any inspection, or
to disclose any information,  that in the reasonable judgment of Markland or the
Company, as the case may be, would result in the disclosure of any trade secrets
of  third   parties  or  violate  any  of  its   obligations   with  respect  to
confidentiality if Markland or the Company,  as the case may be, shall have used
all  reasonable  efforts  to obtain  the  consent  of such  third  party to such
inspection or  disclosure.  All requests for  information  made pursuant to this
Section  7.2 shall be  directed  to an  executive  officer  of  Markland  or the
Company,  as the case may be, or such  Person as may be  designated  by any such
executive officer, as the case may be.

                                       12
<PAGE>

       (b) Subject to applicable Laws relating to the exchange of information,
from the Agreement  Date to the Closing Date,  the Company and Markland agree to
consult  with each  other on a regular  basis on a  schedule  to be agreed  with
regard to their respective operations.

7.3 Other Actions; Notification.

       (a) The Company and Markland shall cooperate with each other and use
(and  shall  cause  their  respective  Subsidiaries  to  use)  their  respective
reasonable best efforts (i) to take or cause to be taken all actions,  and do or
cause to be done all things,  necessary,  proper or  advisable on its part under
this  Agreement and the  applicable  Laws to consummate  and make  effective the
Exchange and the other  transactions  contemplated  by this Agreement as soon as
practicable,  including (A) obtaining opinions of their respective  accountants,
if  required,   (B)  preparing  and  filing  as  promptly  as  practicable   all
documentation to effect all necessary applications,  notices, petitions, filings
and other  documents,  and (C)  instituting  court actions or other  proceedings
necessary to obtain the  approvals  required to  consummate  the Exchange or the
other  transactions  contemplated  by this  Agreement  or defending or otherwise
opposing all court actions or other  proceedings  instituted  by a  Governmental
Entity or other  Person for  purposes  of  preventing  the  consummation  of the
Exchange and the other  transactions  contemplated by this Agreement and (ii) to
obtain as  promptly  as  practicable  all  consents,  registrations,  approvals,
permits and authorizations  necessary or advisable to be obtained from any third
party and/or any Governmental  Entity in order to consummate the Exchange or any
of the other  transactions  contemplated by this Agreement;  provided,  however,
that nothing in this Section  7.3(a) shall require  either party to agree to any
divestitures  or hold  separate  or  similar  arrangements  in order  to  obtain
approval of the transactions contemplated by this Agreement if such divestitures
or arrangements  would  reasonably be expected to have a Material Adverse Effect
on the  Company  or  Markland,  or a  Material  Adverse  Effect on the  expected
benefits of the Exchange to the Company or Markland.  Subject to applicable Laws
relating to the exchange of information, the Company and Markland shall have the
right to review in advance,  and to the extent practicable each will consult the
other on, all the information  relating to the Company or Markland,  as the case
may be, and any of their respective Subsidiaries, that appear in any filing made
with, or written materials submitted to, any third party and/or any Governmental
Entity in connection with the Exchange and the other  transactions  contemplated
by this Agreement.  In exercising the foregoing  right,  each of the Company and
Markland shall act reasonably and as promptly as practicable.

                                       13
<PAGE>

       (b) The Company and Markland each shall, upon request by the other,
furnish the other with all  information  concerning  itself,  its  Subsidiaries,
directors, officers and shareholders and such other matters as may be reasonably
necessary or advisable in connection with any  Registration  Statement or filing
with the SEC made by Markland or the Company in connection with the Exchange and
the transactions contemplated by this Agreement.

       (c) The Company and Markland each shall keep the other apprised of the
status of matters  relating to completion of the  transactions  contemplated  by
this Agreement, including promptly furnishing the other with copies of notice or
other communications received by the Company or Markland, as the case may be, or
any of its Subsidiaries or, from any third party and/or any Governmental  Entity
with  respect to the Exchange and the other  transactions  contemplated  by this
Agreement.  Each of the Company  and  Markland  shall give prompt  notice to the
other of any change that is  reasonably  likely to result in a Material  Adverse
Effect  on  it or of  any  failure  of  any  conditions  to  the  other  party's
obligations to affect the Exchange.

7.4 Publicity. The initial press release with respect to the Exchange shall be a
joint, mutually agreed press release. Thereafter, Markland and the Company shall
consult with each other prior to issuing any press releases or otherwise making
public announcements with respect to the Exchange and the other transactions
contemplated by this Agreement and prior to making any filings with any third
party and/or any Governmental Entity (including any securities exchange) with
respect thereto, except as may be required by Law or by obligations pursuant to
any listing agreement with or rules of any securities exchange.

7.5 Indemnification of Officers and Directors. The Company agrees that all
rights to indemnification existing in favor of any of the present or former
officers or directors of Markland (the "Managers") as provided in Markland's
Certificate of Incorporation or Bylaws as in effect as of the Closing Date, and
in any agreement between Markland and any Manager with respect to matters
occurring prior to the Closing Date, shall survive the Exchange in accordance
with the terms of the applicable agreements or instruments. The Company further
covenants not to amend or repeal any provisions of the Certificate of
Incorporation or Bylaws of Markland in any manner which would adversely affect
the indemnification or exculpatory provisions contained therein as they pertain
to acts occurring prior to the Closing. The provisions of this Section 7.5 are
intended to be for the benefit of, and shall be enforceable by, each indemnified
party and his or her heirs and representatives.

7.6 Post-Exchange Indemnification. If the Company or any of its successors or
assigns (i) shall consolidate with or merge into any other corporation or entity
and shall not be the continuing or surviving corporation or entity of such
consolidation or merger or (ii) shall transfer all or substantially all of its
properties and assets to such Person, then and in each such case, proper
provisions shall be made so that the successors and assigns of the Company shall
assume all of the obligations set forth in Section 7.5.

                                       14
<PAGE>

7.7 Reverse Split. As soon as practicable following to the Closing Date, the
Company, as majority shareholder of Markland, shall take all actions required by
it to implement a 1-for-20 reverse split of Markland's issued and outstanding
shares of Markland Common Stock in accordance with the provisions of Florida
General Corporation Law.

7.8 Restricted Cash; No Up-Streaming. Any and all cash and other current
(liquid) assets at any time held by Markland or its Subsidiaries shall be for
the exclusive use of Markland and such Subsidiaries, respectively, for working
capital or investment purposes; the Company shall not, and shall not permit the
Company's Subsidiaries to, directly or indirectly divert or upstream cash or
other current assets from either Markland or such Subsidiaries, whether in the
form of a loan, contract for services, declaration of dividend, or other
arrangement in contravention of such restriction.

7.9 Registration Rights. The Exchange Shares and the ipPartners Shares shall
have piggy-back and demand rights with respect to registration on a registration
statement filed by Markland subsequent to the Closing, either on Form S-1 or
other applicable form, for the resale of the Common Stock of the Markland.
Subsequent to the Closing, Markland and, respectively, the Company and
ipPartners shall enter into separate piggy-back and demand registration rights
agreements for the registration, in a commercially reasonable manner and
timeframe, of the Exchange Shares and the ipPartners Shares.

                                 ARTICLE VIII.

                                   Conditions

8.1 Conditions to Each Party's Obligation to Effect the Exchange. The respective
obligation of each party to effect the Exchange is subject to the satisfaction
or waiver, if applicable, at or prior to the Closing Date, of each of the
following conditions:

       (a) Exhibits  and  Schedules.  The  Exhibits  and  Schedules  shall have
been  delivered  and  accepted by the Company and Markland (such acceptance to
be in each party's sole and absolute discretion);

       (b) Each of the Company and Markland shall have completed its respective
continuing business, legal and accounting due diligence review, shall be
satisfied with the results of such review in each's sole and absolute
discretion, and shall have notified the other that it has completed such review;
and

       (c) Laws and Orders. No Governmental Entity of competent jurisdiction
shall have enacted,  issued,  promulgated,  enforced or entered any Law (whether
temporary, preliminary or permanent) that is in effect and restrains, enjoins or
otherwise  prohibits  consummation  of the  Exchange  or the other  transactions
contemplated by this Agreement  (collectively,  an "Order"), and no Governmental
Entity shall have  instituted  any  proceeding  or  threatened  to institute any
proceeding seeking any such Order.

                                       15
<PAGE>

8.2 Condition to Obligations of the Company. The obligations of the Company to
effect the Exchange are also subject to the satisfaction or waiver by the
Company at or prior to the Closing Date of the following conditions:

       (a) Representations and Warranties. The representations and warranties of
Markland and Markland Shareholders set forth in this Agreement (i) to the extent
qualified by Material Adverse Effect shall be true and correct and (ii) to the
extent not qualified by Material Adverse Effect shall be true and correct
(except that this clause (ii) shall be deemed satisfied so long as any failures
of such representations and warranties to be true and correct, taken together,
would not reasonably be expected to have a Material Adverse Effect on Markland
and would not reasonably be expected to have a material adverse effect on the
expected benefits of the Exchange to the Company), in the case of each of (i)
and (ii), as of the Agreement Date and (except to the extent such
representations and warranties speak as of an earlier date) as of the Closing
Date as though made on and as of the Closing Date;

       (b) Performance  of  Obligations  of Markland.  Markland  shall have
performed in all material  respects all obligations  required to be performed by
it under this Agreement at or prior to the Closing Date,  including the issuance
of the Exchange Shares to the Company;

       (c) Consents Under Agreements.Markland shall have obtained the consent or
approval of each Person whose consent or approval shall be required in order to
consummate the transactions contemplated by this Agreement under any Contract to
which Markland is a party, except those for which the failure to obtain such
consent or approval, individually or in the aggregate, is not reasonably likely
to have a Material Adverse Effect on Markland or a material adverse effect on
the expected benefits of the Exchange to Company;

       (d) Exchange of Outstanding Convertible Securities. Certain outstanding
promissory notes convertible into Markland Common Stock shall be exchanged for
shares of a new series of Series C convertible preferred stock of Markland,
prior to or simultaneously with the Exchange in accordance with that certain
Exchange Agreement to be entered into between Markland the holders of such
promissory notes;

       (e) Retirement of Markland Common Stock.  The Markland Shareholders shall
 have  effected  the  Share Surrender; and

       (f) Retirement Pledge and Security Agreement.   Woodward LLC shall have
entered  into that  certain  Retirement,  Pledge and  Security  Agreement  to be
entered into between the Company and Woodward LLC.

8.3 Conditions to Obligation of Markland. The obligation of Markland to effect
the Exchange is also subject to the satisfaction or waiver by Markland at or
prior to the Closing Date of the following conditions:

       (a) Representations and Warranties. The representations and warranties of
the Company, Crypto and ipPartners set forth in this Agreement (i) to the extent
qualified by Material Adverse Effect shall be true and correct, and (ii) to the
extent not qualified by Material Adverse Effect shall be true and correct
(except that this clause (ii) shall be deemed satisfied so long as any failures
of such representations and warranties to be true and correct, taken together,
would not reasonably be expected to have a Material Adverse Effect on the
Company and would not reasonably be expected to have a material adverse effect
on the expected benefits of the Exchange to Markland), in the case of each of
(i) and (ii), as of the Agreement Date and (except to the extent such
representations and warranties speak as of an earlier date) as of the Closing
Date as though made on and as of the Closing Date;

                                       16
<PAGE>

       (b) Performance of Obligations of the Company. The Company shall have
performed  and have  caused  Crypto to  perform  in all  material  respects  all
obligations  required to be performed by it under this  Agreement at or prior to
the Closing Date including the transfer of the Transferred Property to STI; and

       (c) Consents Under Agreements. The Company shall have obtained, and have
caused Crypto to obtain, the consent or approval of each Person whose consent or
approval shall be required in order to consummate the transactions  contemplated
by this Agreement  under any Contract to which the Company or Crypto is a party,
except  those  for  which  the  failure  to obtain  such  consent  or  approval,
individually  or in the aggregate,  is not reasonably  likely to have a Material
Adverse  Effect on the Company or Crypto,  or a material  adverse  effect on the
expected benefits of the Exchange to Markland.

                                  ARTICLE IX.

                                   Termination

9.1 Termination by Mutual Consent. This Agreement may be terminated and the
Exchange may be abandoned at any time prior to the Closing Date by mutual
written consent of Markland and the Company, through action of their respective
Boards of Directors.

9.2 Termination by Either Company or Markland. This Agreement may be terminated
and the Exchange may be abandoned at any time prior to the Closing Date by
action of the Board of Directors of either Company or Markland if (i) the
Exchange shall not have been consummated by December 15, 2002 (the "Termination
Date"), or (ii) any Order permanently restraining, enjoining or otherwise
prohibiting consummation of the Exchange shall become final and non-appealable
(whether before or after the adoption or approval by the Stockholders);
provided, that the right to terminate this Agreement pursuant to clause (i)
above shall not be available to any party that has breached in any material
respect its obligations under this Agreement in any manner that shall have
approximately contributed to the failure of the Exchange to be consummated.

9.3 Effect of Termination and Abandonment. In the event of termination of this
Agreement and the abandonment of the Exchange in accordance with the provisions
of this Article, this Agreement shall become void and of no effect with no
liability on the part of any party to this Agreement or of any of its directors,
officers, employees, agents, legal or financial advisors or other
representatives; provided, however, no such termination shall relieve any party
to this Agreement from any liability for damages resulting from any breach of
this Agreement.

                                       17
<PAGE>

                                   ARTICLE X.

                          Indemnification and Survival

10.1 Survival; Right to Indemnification Not Affected by Knowledge. All
representations, warranties, covenants and obligations in this Agreement, and
any certificate or document delivered pursuant to this Agreement, shall survive
the closing until the second anniversary of the Closing Date. The right to
indemnification and payment of damages for third party claims based on such
representations, warranties, covenants and obligations will not be affected by
any investigation conducted with respect to, or any knowledge acquired (or
capable of being acquired) at any time, whether before or after the execution
and delivery of this Agreement or the Closing Date, with respect to the accuracy
or inaccuracy of or compliance with, any such representation, warranty, covenant
or obligation. The waiver of any condition based on the accuracy of any
representation or warranty, or on the performance of or compliance with any
covenant or obligation, will not affect the right to indemnification, payment of
damages for third party claims based on such representations, warranties,
covenants and obligations.

10.2 Indemnification and Payment of Damages by Markland. Markland will indemnify
and hold harmless the Company and will pay to the Company the amount of any
damages arising, directly or indirectly, from or in connection with third party
claims with respect to (a) any material breach of any representation or warranty
made by Markland in this Agreement or any other certificate or document
delivered by Markland pursuant to this Agreement, or (b) any material breach by
Markland of any agreement, covenant or obligation of Markland in this Agreement.
Any indemnity pursuant to this Section 10.2 shall only be available to the
extent that such damages pursuant to (a) or (b) above exceed $25,000 in
aggregate.

10.3 Indemnification and Payment of Damages by the Company. The Company will
indemnify and hold harmless Markland, and will pay to Markland the amount of any
damages arising, directly or indirectly, from or in connection with third party
claims with respect to (a) any material breach of any representation or warranty
made by the Company in this Agreement or in any certificate delivered by the
Company pursuant to this Agreement or (b) any material breach by the Company of
any agreement, covenant or obligation of the Company in this Agreement. Any
indemnity pursuant to this Section 10.3 shall only be available to the extent
that such damages pursuant to (a) or (b) above exceed $25,000 in aggregate.

10.4     Procedure for Indemnification - Third Party Claims.

       (a) Promptly after receipt by an indemnified party under Section 10.2 or
10.3  of  notice  of  the   commencement   of  any  proceeding   against  it  (a
"Proceeding"),  such indemnified party will, if a claim is to be made against an
indemnifying party under such Section,  give notice to the indemnifying party of
the commencement of such claim, but the failure to notify the indemnifying party
will not relieve the indemnifying party of any liability that it may have to any
indemnified party, except to the extent that the indemnifying party demonstrates
that the  defense  of such  action is  prejudiced  by the  indemnifying  party's
failure to give such notice.

                                       18
<PAGE>

       (b) If any Proceeding referred to in Section 10.4(a) is brought against
an  indemnified  party  and it gives  notice  to the  indemnifying  party of the
commencement of such Proceeding,  the indemnifying  party will, unless the claim
involves Taxes, be entitled to participate in such Proceeding and, to the extent
that it  wishes  (unless  (i) the  indemnifying  party  is also a party  to such
Proceeding  and the  indemnified  party  determines  in good  faith  that  joint
representation  would be inappropriate,  or (ii) the indemnifying party fails to
provide reasonable  assurance to the indemnified party of its financial capacity
to defend such  Proceeding  and  provide  indemnification  with  respect to such
Proceeding),  to assume the defense of such Proceeding with counsel satisfactory
to the indemnified  party and, after notice from the  indemnifying  party to the
indemnified party of its election to assume the defense of such Proceeding,  the
indemnifying party will not, as long as it diligently  conducts such defense, be
liable  to the  indemnified  party  under  this  ARTICLE X for any fees of other
counsel or any other expenses with respect to the defense of such Proceeding, in
each case subsequently  incurred by the indemnified party in connection with the
defense of such Proceeding, other than reasonable costs of investigation. If the
indemnifying  party  assumes  the  defense  of a  Proceeding,  (i)  it  will  be
conclusively  established for purposes of this Agreement that the claims made in
that Proceeding are within the scope of and subject to indemnification;  (ii) no
compromise  or  settlement  of such claims may be  effected by the  indemnifying
party without the indemnified  party's consent unless (A) there is no finding or
admission of any violation of a Law or any violation of the rights of any Person
and no effect on any  other  claims  that may be made  against  the  indemnified
party,  and (B) the sole relief  provided is monetary  damages  that are paid in
full by the  indemnifying  party;  and (iii) the indemnified  party will have no
liability with respect to any  compromise or settlement of such claims  effected
without  its  consent.  If  notice  is  given  to an  indemnifying  party of the
commencement of any Proceeding and the  indemnifying  party does not, within ten
business days after the indemnified  party's notice is given, give notice to the
indemnified party of its election to assume the defense of such Proceeding,  the
indemnifying party will be bound by any determination made in such Proceeding or
any compromise or settlement effected by the indemnified party.

(c) Notwithstanding the foregoing, if an indemnified party determines in good
faith that there is a reasonable probability that a Proceeding may adversely
affect it or its Affiliates other than as a result of monetary damages for which
it would be entitled to indemnification under this Agreement, the indemnified
party may, by notice to the indemnifying party, assume the exclusive right to
defend, compromise, or settle such Proceeding, but the indemnifying party will
not be bound by any determination of a Proceeding so defended or any compromise
or settlement effected without its consent (which may not be unreasonably
withheld).

(d) Notwithstanding Section 12.4 hereof, each of the Company and Markland hereby
consents to the non-exclusive jurisdiction of any court in which a Proceeding is
brought against any indemnified party for purposes of any claim that an
indemnified party may have under this Agreement with respect to such Proceeding
or the matters alleged therein.

                                       19
<PAGE>

                                  ARTICLE XI.

              Patriot Act and Other Representations of the Parties

11.1 Patriot Act and Other Representations. Markland and the Markland
Shareholders (one the one hand) and the Company and Crypto and ipPartners (on
the other hand) hereby represent and warrant to each other that such parties (i)
are not included on any Government List (as defined below), (ii) are not persons
who has been determined by a Governmental Entity to be subject to the
prohibitions contained in Executive Order No. 13224 (Sept. 23, 2001) or any
other similar prohibitions contained in the rules and regulations of Office of
Foreign Assets Control ("OFAC") and/or in any enabling legislation or other
Executive Orders in respect thereof, (iii) to the actual knowledge of the
parties, based upon reasonable investigation, are not owned or controlled by, or
acts for or on behalf of, any person on any Government List or any other person
who has been determined by a Governmental Entity to be subject to the
prohibitions contained in Executive Order No. 13224 (Sept. 23, 2001) or similar
prohibitions contained in the rules and regulations of OFAC or any enabling
legislation or other Executive Orders in respect thereof, (iv) are in compliance
with Executive Order No. 13224 (September 23, 2001), the rules and regulations
of the OFAC, Department of Treasury or other Executive Orders in respect thereof
to which such parties have actual knowledge or should have known based upon
reasonable investigation, (v) have not been (and are not currently being)
investigated by any Governmental Authority for, or indicted for, any Patriot Act
Offense (as defined below) and/or (vi) are not under investigation by any
Governmental Entity for alleged criminal behavior.

11.2     Certain Definitions.  For purposes of this Agreement:

       (a) The term "Government List" means (i) the Specially Designated
Nationals and Blocked  Persons List  maintained by the Office of Foreign  Assets
Control,  U.S.  Department of the Treasury or (ii) any other list of terrorists,
terrorist  organizations or narcotics traffickers  maintained pursuant to any of
the rules and regulations of Office of Foreign Assets Control,  U.S.  Department
of the Treasury,  or (iii) any similar list maintained by the U.S. Department of
State, the U.S. Department of Commerce or pursuant to any Executive Order of the
President of the United States.

       (b) The term "Patriot Act Offense" means any violation of the criminal
laws of the United States of America or any of the several  states  therein,  or
that would be a criminal  violation if committed  within the jurisdiction of the
United  States of America or any of the  several  states  therein,  relating  to
terrorism or the laundering of monetary instruments, including any offense under
(i) the Bank Secrecy Act, as amended,  (ii) the Money Laundering  Control Act of
1986, as amended, or (iii) the Uniting and Strengthening of America by Providing
Appropriate Tools Required to Intercept and Obstruct Terrorism (USA PATRIOT ACT)
Act of 2001,  Public Law 107-56 (October 26, 2001), in each case as the same may
be  amended  from  time to  time,  and the  rules  and  regulations  promulgated
thereunder and  corresponding  provisions of future laws.. The term "Patriot Act
Offense"  also  includes  the  crimes of  conspiracy  to  commit,  or aiding and
abetting another to commit, a Patriot Act Offense.

                                       20
<PAGE>

                                  ARTICLE XII.

                            Miscellaneous and General

12.1 Modification or Amendment. Subject to the provisions of the applicable law,
the parties to this Agreement may modify or amend this Agreement by written
agreement executed and delivered by a duly authorized officer of the respective
parties.

12.2 Waiver.

       (a) Any provision of this Agreement may be waived prior to the Closing
Date if, and only if, such waiver is in writing and executed and  delivered by a
duly authorized officer of the respective parties.

       (b) No failure or delay by any party in exercising any right, power or
privilege  under this Agreement  shall operate as a waiver thereof nor shall any
single or  partial  exercise  thereof  preclude  any other or  further  exercise
thereof  or the  exercise  of any other  right,  power or  privilege.  Except as
otherwise  provided in this  Agreement,  the rights and remedies herein provided
shall be cumulative and not exclusive of any rights or remedies provided by Law.

12.3 Counterparts. This Agreement may be executed in any number of counterparts,
and by facsimile, each such counterpart being deemed to be an original
instrument, and all such counterparts shall together constitute the same
agreement.

12.4     Governing Law and Venue; Waiver of Jury Trial.

       (a) This Agreement shall be deemed to be made in and in all respects
shall be interpreted,  construed and governed by and in accordance with New York
law  without  regard to the  conflict  of law  principles  thereof,  except that
matters  relating to the corporate  governance of Markland  shall be governed by
Florida law.  The parties  hereby  irrevocably  and  unconditionally  consent to
submit to the exclusive  jurisdiction of the courts of the State of New York and
of the United  States of America  located in the Borough of Manhattan  (the "New
York Courts") for any  litigation  arising out of or relating to this  Agreement
and the  transactions  contemplated by this Agreement (and agree not to commence
any  litigation  relating  thereto  except in such New York  Courts),  waive any
objection to the laying of venue of any such  litigation  in the New York Courts
and  agree  not to plead or claim in any New York  Court  that  such  litigation
brought therein has been brought in an inconvenient forum.

       (b) Each party acknowledges and agrees that any controversy which may
arise  under this  Agreement  is likely to  involve  complicated  and  difficult
issues, and therefore each party hereby irrevocably and  unconditionally  waives
any right such  party may have to a trial by jury in  respect of any  litigation
directly or  indirectly  arising out of or  relating to this  Agreement,  or the
transactions   contemplated  by  this   Agreement.   Each  party  certifies  and
acknowledges  that (i) no  representative,  agent or attorney of any other party
has represented, expressly or otherwise, that such other party would not, in the
event of litigation,  seek to enforce the foregoing waiver, (ii) each such party
understands and has considered the implications of this waiver, (iii) each party
makes this  waiver  voluntarily,  and (iv) each party has been  induced to enter
into  this   Agreement   by,  among  other  things,   the  mutual   waivers  and
certifications in this Section 12.4.

                                       21
<PAGE>

12.5 Notices. Notices, requests, instructions or other documents to be given
under this Agreement shall be in writing and shall be deemed given, (i) three
business days following sending by registered or certified mail, postage
prepaid, (ii) when sent if sent by facsimile, provided that written or other
confirmation of receipt is obtained by the sending party, (iii) when delivered,
if delivered personally to the intended recipient, and (iv) one business day
later, if sent by overnight delivery via a national courier service, and in each
case, addressed to a party at the following address for such party:

         If to the Company or Crypto:

         Eurotech, Ltd.
         10306 Eaton Place, Suite 220
         Fairfax, VA 22030
         Attention:  Don Hahnfeldt, President
         Fax:  703-352-5994

         with a copy (which shall not constitute notice) to:

         Ellenoff, Grossman, Schole & Cyruli, LLP
         370 Lexington Avenue
         New York, NY 10017
         Attention:  Barry I. Grossman
         Fax: 212-370-7889

         If to ipPartners:

         ipPartners, Inc.
         P.O. Box 1490
         Coventry, Rhode Island 02816
         Attn:  President
         Fax: 401-454-1806

         If to Markland:

         Markland Technologies, Inc.
         #207
         54 Danbury Road
         Ridgefield, CT  06877
         Attention:  Larry Shatsoff, President
         Fax: 203-431-0993

                                       22
<PAGE>

         If to STI:

         Security Technology, Inc.
         #207
         54 Danbury Road
         Ridgefield, CT  06877
         Attention:  Ken Ducey
         Fax: 203-431-0993

         If to the Markland Shareholders:

         P.O Box 866, George Town
         Anderson Square Building, Shedden Road
         Grand Cayman, Cayman Islands
         Attn:  Director
         Fax: 345-949-8492

12.6 Entire Agreement. This Agreement (including any schedules or exhibits to
this Agreement) constitute the entire agreement, and supersede all other prior
agreements, understandings, representations and warranties both written and
oral, among the parties, with respect to the subject matter of this Agreement.
Each party to this Agreement agrees that, except for the representations and
warranties contained in this Agreement, neither the Company nor Markland makes
any other representations or warranties, and each hereby disclaims any other
representations or warranties made by itself or any of its officers, directors,
employees, agents, financial and legal advisors or other representatives, with
respect to the execution and delivery of this Agreement or the transactions
contemplated by this Agreement, notwithstanding the delivery or disclosure to
the other or the other's representatives of any documentation or other
information with respect to any one or more of the foregoing.

12.7 No Third Party Beneficiaries. Except as provided in Section 7.5 and 7.6,
this Agreement is not intended to confer upon any Person other than the parties
to this Agreement any rights or remedies under this Agreement.

12.8 Obligations of the Parent. Whenever this Agreement requires a Subsidiary of
either the Company or Markland to take any action, such requirement shall be
deemed to include an undertaking on the part of the Company, or Markland,
respectively, to cause such Subsidiary to take such action. For purposes of this
Agreement, the term "Subsidiary" shall mean, when used with reference to any
party hereto, any corporation or other entity of which such party or any other
subsidiary of such party directly or indirectly (i) is a general or managing
partner or managing member, (ii) owns (A) a majority of the outstanding voting
securities or interests of which, having by their terms ordinary voting power to
elect a majority of the board of directors or others performing similar
functions with respect to such corporation or other entity or (B) securities in
such corporation or entity which grant such party or its subsidiary the right to
perform or approve management functions of such corporation or entity or (iii)
owns more than fifty percent (50%) of the value of the outstanding equity
securities or interests (including membership interests) of which are owned
directly or indirectly by such party.

                                       23
<PAGE>

12.9 Severability. The provisions of this Agreement shall be deemed severable
and the invalidity or unenforceability of any provision shall not affect the
validity or enforceability or the other provisions of this Agreement. If any
provision of this Agreement, or the application thereof to any Person or any
circumstance, is invalid or unenforceable, (a) a suitable and equitable
provision shall be substituted therefore in order to carry out, so far as may be
valid and enforceable, the intent and purpose of such invalid or unenforceable
provision and (b) the remainder of this Agreement and the application of such
provision to other Persons or circumstances shall not be affected by such
invalidity or unenforceability, nor shall such invalidity or unenforceability
affect the validity or enforceability of such provision, or the application
thereof, in any other jurisdiction.

12.10 Interpretation. The table of contents and headings in this Agreement are
for convenience of reference only, do not constitute part of this Agreement and
shall not be deemed to limit or otherwise affect any of the provisions of this
Agreement. Where a reference in this Agreement is made to a schedule, such
reference shall be to a schedule to this Agreement unless otherwise indicated.
Whenever the words "include," "includes" or "including" are used in this
Agreement, they shall be deemed to be followed by the words "without
limitation."

12.11 Assignment.  This Agreement shall not be assignable by operation of law or
otherwise.  Any assignment in contravention  of the preceding  sentence shall be
null and void.

                                    * * * * *

                                       24
<PAGE>

         IN WITNESS WHEREOF, this Agreement has been duly executed and delivered
by the duly authorized officers of the parties hereto as of the date first
written above.

                                            MARKLAND TECHNOLOGIES, INC.

                                            By:
                                                     ---------------------------
                                            Name:
                                                     ---------------------------
                                            Title:
                                                     ---------------------------

                                            EUROTECH, LTD.

                                            By:
                                                     ---------------------------
                                            Name:
                                                     ---------------------------
                                            Title:
                                                     ---------------------------

                                            CRYPTO.COM, INC.

                                            By:
                                                     ---------------------------
                                            Name:
                                                     ---------------------------
                                            Title:
                                                     ---------------------------

                                            SECURITY TECHNOLOGY, INC.

                                            By:
                                                     ---------------------------
                                            Name:
                                                     ---------------------------
                                            Title:
                                                     ---------------------------

                                            Solely with respect to ARTICLE V and
                                            ARTICLE XI hereof:
                                            IPPARTNERS, INC.

                                            By:
                                                     ---------------------------
                                            Name:
                                                     ---------------------------
                                            Title:
                                                     ---------------------------

<PAGE>

                                            Solely with respect to ARTICLE VI
                                            and ARTICLE XI hereof:
                                            MARKLAND LLC

                                            By:
                                                     ---------------------------
                                            Name:
                                                     ---------------------------
                                            Title:
                                                     ---------------------------

                                            Solely with respect to ARTICLE VI
                                            and ARTICLE XI hereof:
                                            JAMES LLC

                                            By:
                                                     ---------------------------
                                            Name:
                                                     ---------------------------
                                            Title:
                                                     ---------------------------

                 [End of Signature Pages to Exchange Agreement]

<PAGE>

                                    EXHIBIT A

                              Transferred Property

                                       iAs filed with the Securities and Exchange Commission on September ___, 2001

	
Exhibit 4.4

	 
	
CULLEN/FROST BANKERS, INC. 

	
1997 DIRECTOR STOCK PLAN

	 
	
Article 1.     Establishment, Objectives, and Duration

	 
	
1.1     Establishment of the Plan.  Cullen/Frost Bankers, Inc., a Texas corporation (hereinafter, together with its Subsidiaries and successors thereto as provided in Article 10 herein, referred to as the "Company"), hereby establishes an incentive compensation plan to be known as the "1997 Director Stock Plan" (the "Plan"), as set forth in this document.  The Plan permits the grant of Nonqualified Stock Options.

	 
	
Subject to approval by the Company's stockholders, the Plan shall become effective as of May 28, 1997 (the "Effective Date") and shall remain in effect as provided in Section 1.3 hereof.

	 
	
1.2     Objectives of the Plan.  The objectives of the Plan are to link the interests of Outside Directors to those of the Company's stockholders by providing for the ability to pay some or all of the Outside Directors' compensation through stock options and to optimize the profitability and growth of the Company through incentives which are consistent with the Company's goals.

	 
	
The Plan is further intended to provide flexibility to the Company in its ability to motivate, attract, and retain the services of Outside Directors who make significant contributions to the Company's success and to allow Outside Directors to share in the success of the Company.

	 
	
1.3     Duration of the Plan.  The Plan shall commence on the Effective Date, as described in Section 1.1 hereof, and shall remain in effect, subject to the right of the Committee to amend or terminate the Plan at any time pursuant to Article 8 hereof, until all Shares subject to it shall have been purchased or acquired according to the Plan's provisions.

	 
	
Article 2.     Definition

	 
	
Whenever used in the Plan, the following terms shall have the meanings set forth below, and when the meaning is intended, the initial letter of the word shall be capitalized:

	 
	
2.1     "Award" means, individually or collectively, a grant under this Plan or Nonqualified Stock Options.

	 
	
2.2     "Award Agreement" means an agreement entered into by the Company and each Outside Director setting forth the terms and provisions applicable to Awards granted under this Plan.

	 
	
2.3     "Board" or "Board of Directors" means the Board of Directors of Cullen/Frost Bankers, Inc.

	 
	
2.4     "Code" means the Internal Revenue Code of 1986, as amended from time to time.

	 
	
2.5     "Committee" means the Compensation and Benefits Committee appointed by the Board to administer Awards to Outside Directors, as specified in Article 3 herein.  Any such Committee shall be comprised entirely of Outside Directors.

	 
	
2.6     "Director" means any individual who is a member of the Board of Directors of Cullen/Frost Bankers, Inc.

	 
	
2.7     "Employee" means any employee of the Company.  Directors who are employed by the Company shall be considered Employees under this Plan.

	 
	
2.8     "Exchange Act" means the Securities Exchange Act of 1934, as amended from time to time, or any successor act thereto.

	 
	
2.9     "Fair Market Value" shall be determined for a relevant date on the basis of the closing price of the Shares on the NASDAQ National Market, or any other national stock exchange on which the Shares are traded, or if there is no such sale on the relevant date, on the last preceding trading day on which such Shares were traded.

	 
	
2.10     "Nonqualified Stock Option" or "NQSO" means an option to purchase Shares granted under Article 5 herein and which is not intended to meet the requirements of Code Section 422.

	 
	
2.11     "Option Price" means the price at which a Share may be purchased by an Outside Director pursuant to an NQSO.

	 
	
2.12     "Outside Director" means an individual who is a member of the Board of Directors, but who is not an Employee of the Company.

	 
	
2.13     "Shares" means the shares of Common Stock, par value $0.01 per share, of the Company.

	 
	
2.14      "Subsidiary" means any corporation, partnership, joint venture, or other entity in which the Company has a majority voting interest.

	 
	
Article 3.     Administration

	 
	
3.1     General.  The Plan shall be administered by the Committee.  The members of the Committee shall be appointed from time to time by, and shall serve at the discretion of, the Board of Directors.

	 
	
3.2     Authority of the Committee.  Except as limited by law or by the Articles of Incorporation or Bylaws of the Company, and subject to the provisions herein, the Committee shall have full power to determine the sizes and types of Awards; determine the terms and conditions of Awards in a manner consistent with the Plan; construe and interpret the Plan and any agreement or instrument entered into under the Plan; establish, amend, or waive rules and regulations for the Plan's administration; and (subject to the provisions of Article 8 herein) amend the terms and conditions of any outstanding Award as provided in the Plan.  Further, the Committee shall make all other determinations which may be necessary or advisable for the administration of the Plan.  As permitted by law, the Committee shall have the authority to delegate administrative duties to officers or Directors of the Company, and the Committee may otherwise delegate its authority as identified herein.

	 
	
3.3     Decisions Binding.  All determinations and decisions made by the Committee pursuant to the provisions of the Plan and all related orders and resolutions of the Committee shall be final, conclusive and binding on all persons, including the Company, its stockholders, Directors, Employees, and their estates and beneficiaries.

	 
	
Article 4.     Shares Subject to the Plan

	 
	
4.1     Number of Shares Available for Grants.  Subject to adjustment as provided in Section 4.2 herein, the number of Shares hereby reserved for issuance to Outside Directors under the Plan shall be no more than five hundred fifty thousand (550,000).  The Committee shall determine the appropriate methodology for calculating the number of shares issued pursuant to the Plan.  The maximum aggregate number of Shares that may be granted in the form of Nonqualified Stock Options granted in any one fiscal year under the Plan to any one Outside Director shall be ten thousand (10,000).

	
4.2     Adjustments in Authorized Shares.  In the event of any change in corporate capitalization, such as a stock split, or a corporate transaction, such as any merger, consolidation, separation, including a spin-off, or other distribution of stock or property of the Company, any reorganization (whether or not such reorganization comes within the definition of such term in Code Section 368) or any partial or complete liquidation of the Company, such adjustment shall be made in the number and class of Shares which may be delivered under Section 4.1, and in the number and class of and/or price of Shares subject to outstanding Awards granted under the Plan, as may be determined to be appropriate and equitable by the Committee, in its sole discretion, to prevent dilution or enlargement of rights; provided, however, that the number of Shares subject to any Award shall always be a whole number.

	 
	
Article 5.     Nonqualified Stock Options

	 
	
5.1     Award of NQSOs.  Subject to the terms and provisions of the Plan, NQSOs may be awarded to Outside Directors in such number, and upon such terms, and at any time and from time to time as shall be determined by the Committee.

	 
	
5.2     Award Agreement.  Each NQSO Award shall be evidenced by an Award Agreement that shall specify the Option Price, the duration of the Option, the number of Shares to which the Option pertains, and such other provisions as the Committee shall determine.

	 
	
5.3     Option Price.  The Option Price for each grant of an NQSO under this Plan shall be at least equal to one hundred percent (100%) of the Fair Market Value of a Share on the date the NQSO is granted.

	 
	
5.4     Duration of Options.  Each NQSO granted to an Outside Director shall expire at such time as the Committee shall determine at the time of grant. 

	 
	
5.5     Exercise of Options:  NQSOs granted under this Article 5 shall be exercisable at such times and be subject to such restrictions and conditions as the Committee shall in each instance approve, which need not be the same for each grant or for each Outside Director.  In no event should the exercise period exceed a maximum of ten years.

	 
	
5.6     Payment.  NQSOs granted under this Article 5 shall be exercised by the delivery of a written notice of exercise to the Company, setting forth the number of Shares with respect to which the NQSO is to be exercised, accompanied by full payment for the Shares.

	 
	
The Option Price upon exercise of any NQSO shall be payable to the Company in full either:  (a) in cash or its equivalent, or (b) by tendering previously acquired Shares having an aggregate Fair Market Value at the time of exercise equal to the total Option Price (provided that the Shares which are tendered must have been held by the Outside Director for at least six (6) months prior to their tender to satisfy the Option Price), or (c) by a combination of (a) and (b).

	 
	
The Committee also may allow cashless exercise as permitted under Federal Reserve Board's Regulation T, subject to applicable securities law restrictions, or by any other means which the Committee determines to be consistent with the Plan's purpose and applicable law.

	 
	
Subject to any governing rules or regulations, as soon as practicable after receipt of a written notification of exercise and full payment, the Company shall deliver to the Outside Director, in the Outside Director's name, Share certificates in an appropriate amount based upon the number of Shares purchased under the NQSO.

	 
	
5.7     Restrictions on Share Transferability.  The Committee may impose such restrictions on any Shares acquired pursuant to the exercise of an NQSO granted under this Article 5 as it may deem advisable, including, without limitation, restrictions under applicable federal securities laws, under the requirements of any stock exchange or market upon which such Shares are then listed and/or traded, and under any blue sky or state securities laws applicable to such Shares.

	 
	
5.8     Termination of Directorship.  Each Outside Director's Award Agreement shall set forth the extent to which the Outside Director shall have the right to exercise the NQSO following termination of the Outside Director's directorship with the Company.  Such provisions shall be determined in the sole discretion of the Committee, shall be included in the Award Agreement entered into with each Outside Director, need not be uniform among all NQSOs issued pursuant to this Article 5, and may reflect distinctions based on the reasons for termination.

	 
	
5.9     Nontransferability of NQSOs.  Except as otherwise provided by the Committee, no NQSO granted under this Article 5 may be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated, other than by will or by the laws of descent and distribution.  Further except as otherwise provided in an Outside Director's Award Agreement, all NQSOs granted to an Outside Director under this Article 5 shall be exercisable during his lifetime only by such Outside Director.

	 
	
Article 6.     Beneficiary Designation

	 
	
Each Outside Director under the Plan may, from time to time, name any beneficiary or beneficiaries (who may be named contingently or successively) to whom any benefit under the Plan is to be paid in case of his or her death before he or she receives any or all of such benefit.  Each such designation shall revoke all prior designations by the same Outside Director, shall be in a form prescribed by the Company, and will be effective only when filed by the Outside Director in writing with the Company during the Outside Director's lifetime.  In the absence of any such designation, benefits remaining unpaid at the Outside Director's death shall be paid to the Outside Director's estate.

	 
	
Article 7.     Rights of Directors

	 
	
Nothing in the Plan shall interfere with or limit in any way the right of the Company's shareholders to terminate any Outside Director's service at any time, nor confer upon any Outside Director any right to continue in the service of the Company.

	 

 

	
Article 8.     Amendment, Modification, and Termination

	 
	
8.1     Amendment, Modification, and Termination.  Subject to the terms of the Plan, the Committee may at any time and from time to time, alter, amend, suspend or terminate the Plan in whole or in part.

	 
	
8.2     Adjustment of Awards Upon the Occurrence of Certain Unusual or Nonrecurring Events.  The Committee may make adjustments in the terms and conditions of, and the criteria included in, Awards in recognition of unusual or nonrecurring events (including, without limitation, the events described in Section 4.2 hereof) affecting the Company or the financial statements of the Company or of changes in applicable laws, regulations, or accounting principles, whenever the Committee determines that such adjustments are appropriate in order to prevent dilution or enlargement of the benefits or potential benefits intended to be made available under the Plan.

	 
	
8.3     Awards Previously Granted.  Notwithstanding any other provision of the Plan to the contrary, no termination, amendment, or modification of the Plan shall adversely affect in any material way any Award previously granted under the Plan, without the written consent of the Outside Director holding such Award.

	 
	
Article 9.     Indemnification

	 
	
Each person who is or shall have been a member of the Committee, or of the Board, shall be indemnified and held harmless by the Company against and from any loss, cost, liability, or expense that may be imposed upon or reasonably incurred by him or her in connection with or resulting from any claim, action, suit, or proceeding to which he or she may be a party or in which he or she may be involved by reason of any action taken or failure to act under the Plan and against and from any and all amounts paid by him or her in settlement thereof, with the Company's approval, or paid by him or her in satisfaction of any judgement in any such action, suit, or proceeding against him or her, provided he or she shall give the Company an opportunity, at its own expense, to handle and defend the same before he or she undertakes to handle and defend it on his or her own behalf.  The foregoing right of indemnification shall not be exclusive of any other rights of indemnification to which such persons may be entitled under the Company's Articles of Incorporation or Bylaws, as a matter of law, or otherwise, or any power that the Company may have to indemnify them or hold them harmless.

	 
	
Article 10.     Successors

	 
	
All obligations of the Company under the Plan with respect to Awards granted hereunder shall be binding on any successor to the Company, whether the existence of such successor is the result of a direct or indirect purchase, merger, consolidation, or otherwise, of all or substantially all of the business and/or assets of the Company.

	 
	
Article 11.     Legal Construction

	 
	
11.1     Gender and Number.  Except where otherwise indicated by the context, any masculine term used herein also shall include the feminine; the plural shall include the singular and the singular shall include the plural.

	 
	
11.2     Severability.  In the event any provision of the Plan shall be held illegal or invalid for any reason, the illegality or invalidity shall not affect the remaining parts of the Plan, and the Plan shall be construed and enforced as if the illegal or invalid provision had not been included.

	 
	
11.3     Requirements of Law.  The granting of Awards and the issuance of Shares under the Plan shall be subject to all applicable laws, rules, and regulations, and to such approvals by any governmental agencies or national securities exchanges as may be required.

	 
	
11.4     Securities Law Compliance.  Transactions under this Plan are intended to comply with all applicable conditions of Rule 16b-3 or its successors under the Exchange Act.  

	 
	
11.5     Governing Law.  The Plan, and all agreements hereunder, shall be construed in accordance with and governed by the laws of the State of Texas.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00046-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00046-of-00352.parquet"}]]